| Sandoz Pharmaceuticals AG - Leuprorelin Sandoz 3 Monate, Fertigspritze mit Implantat |
| 57141 | | 01 | | Leuprorelin Sandoz 3 Monate | | Fertigspritze mit Implantat | | L02AE02 | | Leuprorelin | | 23.07.2008 | | |
|
| Composition |
| leuprorelinum 5 mg ut leuprorelini acetas, acidum polylacticum pro praeparatione. |
| Packungsbestandteile |
| Implant | | | | | | | | Active Agent | Dose |
|---|
| Leuproreline | 5 mg correspond Leuproreline Acetate |
| | BAG: Active Agent | Dose |
|---|
| Leuproreline | 5 mg |
| | | | Inactive agents |
|---|
| Acidum Polylacticum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | syringe(s) | 246.51 | 284.50 | A | SL | Yes |
|
